PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
19383315-9	2008	The enhancement is dependent upon the action of androgens as treatment with the androgen receptor antagonist cyproterone actetate normalized the expression of KLK10, 11, and KLK14 to estrogen-stimulation levels.	cyproterone actetate	109-129	androgen receptor	Homo sapiens	80-97
19383315-9	2008	The enhancement is dependent upon the action of androgens as treatment with the androgen receptor antagonist cyproterone actetate normalized the expression of KLK10, 11, and KLK14 to estrogen-stimulation levels.	cyproterone actetate	109-129	kallikrein related peptidase 10	Homo sapiens	159-164
19383315-9	2008	The enhancement is dependent upon the action of androgens as treatment with the androgen receptor antagonist cyproterone actetate normalized the expression of KLK10, 11, and KLK14 to estrogen-stimulation levels.	cyproterone actetate	109-129	kallikrein related peptidase 14	Homo sapiens	174-179
9630396-5	1998	Newborn males and females, which were treated in utero with the androgen receptor antagonist cyproterone actetate, exhibited significantly reduced aromatase mRNA levels compared with untreated controls.	cyproterone actetate	93-113	androgen receptor	Mus musculus	64-81